000 01426 a2200421 4500
005 20250518094818.0
264 0 _c20210809
008 202108s 0 0 eng d
022 _a1528-3658
024 7 _a10.1186/s10020-020-00161-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeng, Chunhui
245 0 0 _aEstrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression.
_h[electronic resource]
260 _bMolecular medicine (Cambridge, Mass.)
_c04 2020
300 _a33 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aCell Cycle
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aCell Survival
650 0 4 _aCyclins
_xgenetics
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aEstrogens
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aNeoplastic Processes
650 0 4 _aSecurin
_xgenetics
650 0 4 _aTamoxifen
_xpharmacology
700 1 _aZou, Yan
700 1 _aHong, Weiwei
700 1 _aBao, Chunhua
700 1 _aJia, Xiaofeng
773 0 _tMolecular medicine (Cambridge, Mass.)
_gvol. 26
_gno. 1
_gp. 33
856 4 0 _uhttps://doi.org/10.1186/s10020-020-00161-7
_zAvailable from publisher's website
999 _c30840181
_d30840181